Global Non-Invasive Blood Glucose Monitoring Devices Market Research Report 2023

Publication ID:

PB511240337

Publication Date:

November 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Non-invasive Blood Glucose Monitoring Device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.
The global Non-Invasive Blood Glucose Monitoring Devices market is projected to reach US$ 6003.7 million in 2029, increasing from US$ 5097.3 million in 2022, with the CAGR of 2.4% during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Invasive Blood Glucose Monitoring Devices market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
DexCom
Abbott
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated
Segment by Type
Wearable Devices
Non-wearable Devices
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Invasive Blood Glucose Monitoring Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-Invasive Blood Glucose Monitoring Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Blood Glucose Monitoring Devices
1.2 Non-Invasive Blood Glucose Monitoring Devices Segment by Type
1.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Value Comparison by Type (2023-2029)
1.2.2 Wearable Devices
1.2.3 Non-wearable Devices
1.3 Non-Invasive Blood Glucose Monitoring Devices Segment by Application
1.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue 2018-2029
1.4.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales 2018-2029
1.4.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-Invasive Blood Glucose Monitoring Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Manufacturers (2018-2023)
2.4 Global Non-Invasive Blood Glucose Monitoring Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring Devices, Product Type & Application
2.7 Non-Invasive Blood Glucose Monitoring Devices Market Competitive Situation and Trends
2.7.1 Non-Invasive Blood Glucose Monitoring Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Invasive Blood Glucose Monitoring Devices Players Market Share by Revenue
2.7.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Blood Glucose Monitoring Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Invasive Blood Glucose Monitoring Devices Global Non-Invasive Blood Glucose Monitoring Devices Sales by Region: 2018-2029
3.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Region: 2018-2023
3.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Region: 2024-2029
3.3 Global Non-Invasive Blood Glucose Monitoring Devices Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Region: 2018-2029
3.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Region: 2018-2023
3.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Region: 2024-2029
3.4 North America Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.4.1 North America Non-Invasive Blood Glucose Monitoring Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2018-2029)
3.4.3 North America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Blood Glucose Monitoring Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2018-2029)
3.5.3 Europe Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2018-2029)
3.7.3 Latin America Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Type (2018-2029)
4.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Type (2018-2023)
4.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Type (2024-2029)
4.1.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Type (2018-2029)
4.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Type (2018-2029)
4.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Type (2018-2023)
4.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Type (2024-2029)
4.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Type (2018-2029)
4.3 Global Non-Invasive Blood Glucose Monitoring Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Application (2018-2029)
5.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Application (2018-2023)
5.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Application (2024-2029)
5.1.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Application (2018-2029)
5.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Application (2018-2029)
5.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Application (2018-2023)
5.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Application (2024-2029)
5.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Market Share by Application (2018-2029)
5.3 Global Non-Invasive Blood Glucose Monitoring Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 DexCom
6.1.1 DexCom Corporation Information
6.1.2 DexCom Description and Business Overview
6.1.3 DexCom Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 DexCom Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.1.5 DexCom Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Cnoga Medical
6.3.1 Cnoga Medical Corporation Information
6.3.2 Cnoga Medical Description and Business Overview
6.3.3 Cnoga Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cnoga Medical Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.3.5 Cnoga Medical Recent Developments/Updates
6.4 Integrity Applications
6.4.1 Integrity Applications Corporation Information
6.4.2 Integrity Applications Description and Business Overview
6.4.3 Integrity Applications Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Integrity Applications Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.4.5 Integrity Applications Recent Developments/Updates
6.5 Taiwan Biophotonic
6.5.1 Taiwan Biophotonic Corporation Information
6.5.2 Taiwan Biophotonic Description and Business Overview
6.5.3 Taiwan Biophotonic Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Taiwan Biophotonic Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.5.5 Taiwan Biophotonic Recent Developments/Updates
6.6 MediWise
6.6.1 MediWise Corporation Information
6.6.2 MediWise Description and Business Overview
6.6.3 MediWise Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 MediWise Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.6.5 MediWise Recent Developments/Updates
6.7 GlySens Incorporated
6.6.1 GlySens Incorporated Corporation Information
6.6.2 GlySens Incorporated Description and Business Overview
6.6.3 GlySens Incorporated Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlySens Incorporated Non-Invasive Blood Glucose Monitoring Devices Product Portfolio
6.7.5 GlySens Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Blood Glucose Monitoring Devices Industry Chain Analysis
7.2 Non-Invasive Blood Glucose Monitoring Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Blood Glucose Monitoring Devices Production Mode & Process
7.4 Non-Invasive Blood Glucose Monitoring Devices Sales and Marketing
7.4.1 Non-Invasive Blood Glucose Monitoring Devices Sales Channels
7.4.2 Non-Invasive Blood Glucose Monitoring Devices Distributors
7.5 Non-Invasive Blood Glucose Monitoring Devices Customers
8 Non-Invasive Blood Glucose Monitoring Devices Market Dynamics
8.1 Non-Invasive Blood Glucose Monitoring Devices Industry Trends
8.2 Non-Invasive Blood Glucose Monitoring Devices Market Drivers
8.3 Non-Invasive Blood Glucose Monitoring Devices Market Challenges
8.4 Non-Invasive Blood Glucose Monitoring Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

DexCom
Abbott
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂